Introduction
Mutations in the NF2 gene predispose to tumors of the nervous system, mainly schwannomas and meningiomas (Baser et al., 2003) . The NF2 gene encodes the tumor suppressor protein merlin (or schwannomin), which shares overall structural similarity with the highly conserved ERM (ezrin-radixin-moesin) family of proteins (Rouleau et al., 1993; Trofatter et al., 1993) . Merlin and the ERM proteins function as linkers between the plasma membrane and cytoskeleton, where they modulate the morphology, growth and migration of cells (Bretscher et al., 2002) . The proteins have an overall homology of 75-80% at the amino-acid level, and their structure consists of a large N-terminal FERM (Four-point-one, Ezrin, Radixin, Moesin) domain (amino acids 19-314 in merlin), an a-helical region (amino acids 315-491) and a small globular C terminus (amino acids 492-595) (Turunen et al., 1998) .
Merlin exists as two major isoforms, I and II, as a result of alternative splicing of exon 16 (Rouleau et al., 1993) . The two isoforms differ in their C-terminal sequences, but are identical over the first 579 residues. Merlin isoform I is capable of head-to-tail interactions, whereas isoform II is predicted to exist in a constitutively open conformation since it lacks the C-terminal residues implicated in the intramolecular binding (Sherman et al., 1997; Gonzalez-Agosti et al., 1999; Gro¨nholm et al., 1999) .
It has been suggested that phosphorylation regulates merlin's tumor suppressor activity. Shaw et al. (1998) demonstrated that merlin is phosphorylated on several serine and threonine residues, and that the phosphorylation status of merlin varies in response to different growth conditions. Three merlin species with different electrophoretic mobilities have been observed, suggesting that at least three differentially phosphorylated forms of merlin exist. Merlin contains a C-terminal serine 518, which is phosphorylated both by p21-activated kinase (PAK) and protein kinase A (PKA) (Shaw et al., 2001; Kissil et al., 2002; Xiao et al., 2002; Alfthan et al., 2004) . Phosphorylation at this site is predicted to result in a more open conformation incapable of inhibiting cell growth, but instead allowing the activation of Ras signaling pathways leading to cell division (Morrison et al., 2001; Xiao et al., 2002) . When serine 518 is dephosphorylated by the myosin phosphatase MYPT-1-PP1d, the tumor suppressor function of merlin is activated, inhibiting the Ras signaling pathway and leading to growth arrest (Morrison et al., 2001; Jin et al., 2006) . Recently, also two Akt phosphorylation sites, threonine 230 and serine 315, were identified in the N terminus of merlin (Tang et al., 2007) .
Phosphorylation of serine 518 has been shown to enhance merlin-ezrin binding (Alfthan et al., 2004; Rong et al., 2004) and weaken merlin's association with the cytoskeleton (Shaw et al., 2001) . Like ERM proteins, merlin interacts with F-actin, however, only through N-terminal sites (Xu and Gutmann, 1998; Brault et al., 2001) . Even though the FERM domain of merlin is highly similar to the ERM proteins, the first 18 amino acids that precede the FERM domain (Brault et al., 2001; Shimizu et al., 2002) are unique to merlin (Golovnina et al., 2005) . Interestingly, these 18 amino acids have been indicated in the actin binding of merlin (Brault et al., 2001) .
We have previously shown that PKA binds to and phosphorylates merlin (Gro¨nholm et al., 2003; Alfthan et al., 2004) . PKA is a serine/threonine kinase that regulates the activity of several proteins, including the ERM family member ezrin (Zhou et al., 2003) . The cyclic AMP-PKA pathway plays a role in cell division and actin cytoskeleton remodeling (Howe, 2004) , and activation of PKA promotes cell growth and cell cycle progression in Schwann cells (Kim et al., 1997) , the cells susceptible to tumor formation in the NF2 disease. The previously described binding between the a-helical domain of merlin and RIb, one of the four regulatory subunits of PKA, suggests that merlin might function as a protein kinase A-anchoring protein (Gro¨nholm et al., 2003) .
Our previous study identified a PKA site in the N terminus of merlin in addition to the C-terminal serine 518 (Alfthan et al., 2004) . We have now further characterized the N-terminal PKA-catalysed phosphorylation of merlin, and mapped the phosphorylation site to serine 10. In addition, we have studied the role of serine 10 in the regulation of actin cytoskeleton.
Results
Merlin contains two PKA phosphorylation sites, serine 10 in the FERM domain and serine 518 in the C-terminal domain Our previous studies suggested that PKA phosphorylates the N-terminal domain of merlin (Alfthan et al., 2004) . Metabolic labeling was performed to test whether this phosphorylation can be detected in vivo. 293A HEK cells transfected with wild-type (WT) and S518A (mimicking the unphosphorylated residue) merlin-glutathione S-transferase (GST) constructs were incubated with 32 P-labeled orthophosphate together with forskolin and 3-isobutyl-1-methylxanthine (IBMX) to activate PKA or with H89 to inhibit PKA activity. The amount of bound orthophosphate in merlin was compared to the orthophosphate in GST. Forskolin-and IBMX-treated WT merlin showed pronounced phosphorylation, which was reduced but not completely abolished with the PKA inhibitor H89 (Figure 1b) . The amount of bound orthophosphate in merlin S518A was lower than that in WT, but the construct was still phosphorylated. Treatment of S518A with the PKA inhibitor strongly reduced the amount of bound orthophosphate.
With deletion constructs, we further mapped the phosphorylated region in vitro to amino acids 1-100 (data not shown), which contains one serine (S10) and two threonines (T28 and T53). These potential kinase recognition motifs were mutated to non-phosphorylatable alanines and an in vitro phosphorylation reaction was performed with recombinant GST-merlin proteins. Incubation of the fusion proteins with [ (upper panel) . The Coomassie blue staining shows loading of the constructs (lower panel). Merlin 1-100 is phosphorylated by PKA and S10A mutation abolishes the phosphorylation. (d) Merlin 1-547 and merlin 492-595 constructs with serine 10 and/or serine 518 substituted with alanine were used to confirm the PKA phosphorylation of merlin. The double mutant (1-547 S10A þ S518A) is not phosphorylated by PKA.
PKA phosphorylation of merlin M Laulajainen et al 33 P into merlin constructs 1-100, 1-100 T28A and 1-100 T53A, but not into 1-100 S10A or GST (Figure 1c) , indicating that the site phosphorylated by PKA is serine 10.
To verify that serine 10 functions as a substrate residue also in a longer merlin molecule, we mutated the phosphorylatable residues in merlin 1-547. WT merlin could not be used since it is degraded when produced as a GST fusion protein in bacteria. As shown in Figure 1d , incorporation of 33 P was detected both in merlin 1-547 and 1-547 S518A, although phosphorylation of merlin 1-547 S518A was reduced when compared to 1-547. However, when a double mutation (S10A þ S518A) was introduced to merlin 1-547, no phosphorylation could be detected. As expected, the merlin C terminus (amino acids 492-595) was phosphorylated by PKA, but the S518A mutation abolished the phosphorylation. These results indicate that serines 10 and 518 are the only PKA phosphorylation sites present in merlin.
Mutation of serine 10 does not affect serine 518 phosphorylation or ezrin binding Differentially phosphorylated forms of merlin differ in their electrophoretic mobility. Therefore, previous in vivo phosphorylation studies investigated the mobility of merlin mutants in SDS-polyacrylamide gel electrophoresis (PAGE). WT merlin migrates in the gel as a triplet, with the bands corresponding to hyperphosphorylated, phosphorylated and hypophosphorylated forms of the protein (Shaw et al., 1998; Alfthan et al., 2004) . When serine 518 is dephosphorylated or mutated to alanine (S518A), the slowest migrating, hyperphosphorylated form of merlin disappears (Alfthan et al., 2004) . To determine whether PKA phosphorylation of serine 10 induces similar changes in electrophoretic mobility, we generated mutations mimicking unphosphorylated (S10A or S518A) or phosphorylated (S10D or S518D) forms at both PKA phosphorylation sites. Lysates from 293 HEK cells, expressing these mutant proteins, were analysed by SDS-PAGE. Consistent with earlier studies, WT merlin migrated as a triplet in the gel ( Figure 2a) . As previously shown, the hyperphosphorylated merlin band was absent in the S518A mutants. However, we observed all three migrating species in both S10A and S10D, suggesting that phosphorylation of serine 10 does not induce a conformational change that would result in altered electrophoretic mobility. Substitution of serine 10 did not affect the band shift caused by serine 518 phosphorylation, since the slowest migrating merlin WT, S10A and S10D merlin are recognized with the phosphoserine 518 (pS518) pAb, whereas S518A is not detected (upper panel). Expression levels of constructs are shown with merlin KF10 mAb (lower panel). (c) COS-7 cells and Nf2À/À MEFs transfected with WT, S10A, S10D and S518A merlin were stained with antibodies detecting merlin (KF10 mAb, red) and merlin phosphorylated at S518 (pS518 pAb, green). Long cell extensions in WT-and S10A-expressing cells are not stained by pS518 pAb (arrow). Serine 518 phosphorylated merlin is present in shorter protrusions observed in WT-, S10A-and S10D-transfected cells (arrowhead). pS518 Ab does not detect merlin S518A mutant. (d) Non-phosphorylated (À) or PKA phosphorylated ( þ ) GSTmerlin was incubated with purified full-length ezrin. Proteins were run in SDS-PAGE and detected with ezrin 3C12 mAb (upper panel) and merlin with GST pAb (lower panel). Phosphorylation of merlin 1-547 enhances ezrin binding whereas no difference in binding affinity is detected with phosphorylated merlin 1-314 or 1-547 S518A.
PKA phosphorylation of merlin M Laulajainen et al band was present in constructs with S10 mutations. Insoluble fractions of the lysates showed similar results and we could not detect any differences in the solubility of the constructs (data not shown), suggesting that S10 does not markedly regulate the association of merlin with detergent-insoluble cytoskeleton.
To further test whether PKA-induced phosphorylation of serine 10 is a prerequisite for serine 518 phosphorylation and to examine the possible link between the two sites, 293 HEK cells were transfected with the mutated merlin constructs and analysed with an antibody specifically recognizing S518 phosphorylated merlin (pS518 Ab). The expression levels of merlin constructs were verified using merlin KF10 Ab (antibody) (Figure 2b ). Mutation of serine 10 did not reduce the reactivity of pS518 Ab, consistent with the results from the electrophoretic mobility assay. As expected, pS518 Ab did not detect the S518A construct.
To analyse serine 518 phosphorylation of merlin S10 mutants in vivo, COS-7 cells and mouse embryonic fibroblasts lacking merlin (Nf2À/À MEFs) were transfected with the mutants. Overexpression of WT and S10A merlin induced long thin cellular extensions that were not stained with the pS518 Ab. However, serine 518 phosphorylated merlin was present in shorter thicker protrusions observed in WT-, S10A-and S10D-transfected cells (Figure 2c ). These findings suggest that phosphorylation of serine 10 does not directly affect serine 518 phosphorylation.
We have previously shown that PKA phosphorylation of serine 518 promotes merlin-ezrin heterodimerization (Alfthan et al., 2004) . To determine whether serine 10 phosphorylation similarly regulates intermolecular binding with ezrin, we examined the interaction of phosphorylated and unphosphorylated merlin constructs with ezrin in vitro by GST pull-down assays. Equal amounts of merlin constructs were used and the loading was verified by GST antibody. We observed the previously reported effect of serine 518 phosphorylation on ezrin binding, as PKA-treated merlin 1-547 pulled down more full-length ezrin than unphosphorylated merlin 1-547 (Figure 2d ). In contrast, PKAmediated phosphorylation of the merlin N terminus (amino acids 1-314) or 1-547 S518A did not increase merlin-ezrin binding.
Serine 10 affects the morphological changes induced by merlin Overexpressed WT merlin influences cell morphology (Sainio et al., 1997) . To study whether the phenotypic effect of merlin is regulated by modification of serine 10, COS-7 cells and Nf2À/À MEFs were transiently transfected with WT, S10A or S10D merlin either in isoform I or II, and examined by immunofluorescence microscopy.
Overexpression of merlin isoform I (WT) affected cell morphology, leading to an increase in the amount of membrane extensions both in COS-7 cells and Nf2À/À MEFs (Figure 3 ). Merlin isoform II also induced cell projections, but they were often more abundant and longer than those observed with WT isoform I. Expression of merlin S10A resulted in long cellular extensions, and these extensions were even more pronounced in S10A isoform II. Interestingly, S10D expression induced a morphology with dense filopodialike structures but only rarely long cellular projections. These data suggest that phosphorylation of serine 10 regulates merlin-induced cell morphology.
Serine 10 phosphorylation regulates F-actin organization As serine 10 regulates cell morphology and the first 18 amino acids of merlin are involved in actin binding (Brault et al., 2001) , we hypothesized that phosphorylation of serine 10 might affect the interplay between merlin and actin. To study the effect of phosphorylation mutants on actin cytoskeleton organization, Nf2À/À MEFs were transfected with WT, S10A, S10D or S518A merlin. Cells were stained for F-actin and merlin, and lamellipodial structures were analysed by confocal and immunofluorescence microscopy.
Untransfected cells displayed intense F-actin staining in stress fibers, whereas the actin filament staining in WT and S518A merlin-transfected cells showed less pronounced fibers and often a dense cytoplasmic actin network (Figure 4a ). The intensity of cytoplasmic Factin staining was weaker in cells expressing merlin S10A compared to untransfected cells or cells expressing other merlin constructs. S10A cells lacked both stress fibers and the actin filament network seen in cells expressing WT merlin. These cells were also irregularly shaped and made no lamellipodia. Cells transfected with the S10D mutant displayed stress fibers resembling those of untransfected cells.
The amount of F-actin of whole cells, visualized by phalloidin fluorescence intensity, was quantified from WT-, S10A-and S10D-expressing cells and analysed with Image J software (Figure 4b ). The intensity of merlin-transfected cells was normalized to the intensity of untransfected cells. In cells expressing WT merlin, the phalloidin staining was significantly stronger than in untransfected cells, indicating that these cells contain more filamentous actin. A decrease of F-actin was observed in cells expressing S10A, whereas S10D-transfected cells displayed phalloidin intensity most by resembling the untransfected cells.
Merlin S10D protects the actin cytoskeleton from Latrunculin B-induced depolymerization Based on our observation that differentially phosphorylated merlin constructs influence cell morphology and actin cytoskeleton organization, we studied actin dynamics in merlin-transfected cells. Nf2À/À MEFs, transfected with merlin WT, S10A or S10D, were incubated with Latrunculin B (LatB), used to dissociate F-actin. Cells were fixed before or 8 min after LatB treatment, stained for merlin and F-actin, and analysed by immunofluorescence microscopy.
Latrunculin B treatment caused actin depolymerization in WT-transfected cells, and in S10A cells the actin cytoskeleton was completely disrupted (Figure 5 ). However, actin filaments in S10D-expressing cells depolymerized at a slower rate, indicating that this construct stabilizes actin filaments. All merlin constructs relocalized to the cytoplasm as a result of LatB treatment.
Serine 10 phosphorylation regulates cell migration and lamellipodia formation Rapid actin polymerization at the leading edge of a moving cell results in the formation of filopodia and lamellipodia. Since we observed changes in both the morphology and actin organization of merlin-transfected cells, we hypothesized that also cell motility may be affected. Wound-healing assays were performed with Nf2À/À MEFs and Nf2À/À Schwann cells, infected with retro-and adenovirus constructs, respectively, analysed by phase contrast microscopy and wound widths quantified. Both MEFs and Schwann cells lacking merlin filled the wound in 24-48 h, whereas the migration of merlin-infected cells was slower (Figure 6a) . Interestingly, S10A-expressing cells closed the wound even slower than their WT counterparts (Po0.001 in both MEFs and Schwann cells).
The movement of WT-and S10A-expressing cells was also studied by live cell imaging. Merlin constructs were co-transfected into Nf2À/À MEFs with a green fluorescent protein (GFP) vector to allow identification of the merlin-containing cells. S10A-expressing cells did not display lamellipodia seen in WT-transfected cells, but instead the expression promoted the formation of protrusions and extensions (Figure 6b , Supplementary Data). Thus, the migration rate of S10A merlintransfected cells may be reduced because of alterations in lamellipodia formation.
Discussion
Post-translational modifications such as phosphorylation regulate the biological activity of merlin. At low cell density, merlin is phosphorylated and growth permissive, Figure 3 Phenotypic effect of serine 10 mutations. COS-7 cells and Nf2À/À MEFs were transfected with WT, S10A or S10D mutant merlin isoform I (WT) or isoform II and stained with merlin KF10 mAb (COS-7) or merlin pAb A-19 (Nf2À/À MEFs). WT and S10A merlin-expressing cells have long extensions (arrows) not seen in cells expressing S10D. S10D expression induces dense filopodia-like structures (arrowheads) not seen in WT-, isoform II-or S10A-transfected cells.
whereas merlin exists in a hypophosphorylated form as a result of serum deprivation, high cell density or loss of adhesion. The hypophosphorylated form of merlin is growth inhibitory and represents the functionally active tumor suppressor (Shaw et al., 1998; Morrison et al., 2001) . We have previously shown that in addition to PAK, also PKA phosphorylates merlin at serine 518 (Alfthan et al., 2004) . We now identify an additional PKA phosphorylation site in merlin, and present evidence that this phosphorylation site plays a role in merlin's ability to regulate the actin cytoskeleton. The identified PKA phosphorylation site, serine 10, is conserved in merlin homologs in mouse, rat and Xenopus, suggesting that the residue has important functions.
Merlin contains multiple phosphorylated residues, but the only well-characterized phosphorylation site is serine 518 (Shaw et al., 1998, 2001 ; Kissil et al., 2002; Figure 4 Altered F-actin organization in cells expressing merlin mutants. Nf2À/À MEFs transfected with WT, S10A, S10D or S518A were stained with merlin pAb A-19 (green) and phalloidin (red) and analysed with a confocal microscope. (a) Single confocal sections at the plane close to ventral surface are shown. The right panel shows a higher magnification of the marked area. (b) Intensity of phalloidin staining of whole WT-, S10A-and S10D-expressing cells analysed with Image J software after normalization against untransfected control cells. WT cells show increased and S10A cells display decreased phalloidin staining intensity compared to untransfected cells. Xiao et al., 2002; Alfthan et al., 2004) . Phosphorylation of this site participates in the control of cell proliferation, morphology and motility, all important for the tumor suppressor function of merlin. Serine 518 phosphorylation impairs merlin's ability to selfassociate and affects the binding of interacting proteins such as CD44, hepatocyte growth factor-regulated tyrosine kinase substrate, PKA regulatory subunit RIb and tubulin (Gro¨nholm et al., 2003; Rong et al., 2004; Muranen et al., 2007) . To test whether phosphorylation of serine 10 similarly affects the activity of merlin, mutants mimicking both phosphorylated and unphosphorylated S10 were examined for their ability to mediate functions previously described for merlin. Neither form of serine 10 directly affected the phosphorylation of serine 518, and phosphorylation of serine 10 did not enhance binding to ezrin in contrast to phosphorylation of serine 518. These results suggest that phosphorylation of the two PKA sites have distinct functions and is regulated independently of each other.
Merlin is localized underneath the plasma membrane, especially at areas of membrane remodeling (GonzalezAgosti et al., 1996; Sainio et al., 1997) . Phosphorylation of serine 518 promotes the appearance of multiple cell extensions in different cell types Thaxton et al., 2007) , and serine 518 phosphorylated merlin is present at the most peripheral regions of lamellipodia, microspikes and radial membrane protrusions in Schwann cells (Thaxton et al., 2007) . Our data suggest that merlin's phosphorylation state, not only at serine 518 but also at serine 10, influences cell morphology. Merlin S10A expression resulted in the appearance of long cellular extensions. These structures lacked serine 518 phosphorylated merlin, which instead was present in cellular protrusions. In contrast, S10D merlin promoted the formation of multiple short filopodia-like protrusions where serine 518 phosphorylation was apparent. Our data show that only a subset of merlin molecules at specific membrane structures are hyperphosphorylated, suggesting that the phosphorylation status of merlin is tightly regulated. Interestingly, we detected a more prominent cell-extension effect with merlin isoform II containing the S10 mutations, indicating that phosphorylation of serine 10 in a more open merlin molecule is more efficient in promoting changes in cell morphology. This effect might be mediated through actin, since deformation of the cell membrane requires reorganization of actin filaments and merlin isoform II has a different affinity for actin than isoform I (James et al., 2001 ). 
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Cellular transformation is often associated with disorganization of the cell cytoskeleton, which links cytoskeletal alterations to tumor formation. Nf2-deficient schwannoma cells exhibit cytoskeletal abnormalities manifested by membrane ruffling, large surface areas and F-actin instability (Pelton et al., 1998) . It has previously been shown that the merlin FERM domain and isoform II have the ability to stabilize actin filaments and reduce depolymerization rates (James et al., 2001) , whereas PAK phosphorylation of serine 518 weakens merlin's association with the cytoskeleton (Shaw et al., 2001) . Serine 10 appears to be involved in regulating some of the cytoskeletal changes observed, as both F-actin organization and the amount and depolymerization of F-actin were affected by S10 mutations. Interestingly, a drastic decrease of F-actin was detected in S10A-expressing cells, suggesting that dephosphorylation of serine 10 reduces actin filament formation, Figure 6 Mutation of S10 leads to defects in cell migration and lamellipodia formation. (a) Nf2À/À MEFs (upper panel) and Nf2À/À Schwann cells (lower panel) expressing empty vector, merlin WT or merlin S10A were wounded and examined by phase contrast microscopy. Cells lacking merlin filled the wound in 24-48h, whereas cells expressing WT and S10A merlin were slower in their migration. Gray lines show cell monolayer edges. The right panel shows quantification of wound width 24-48 h after wounding. WTand S10A-expressing cells have a significant difference in their migration rate (***Po0.001 in both MEFs and Schwann cells). Mean values±s.d. calculated from four experiments are shown in arbitrary units. (b) Nf2À/À MEFs were co-transfected with GFP-a-actinin and merlin WT or S10A. Live cells expressing merlin were chosen by their GFP expression and imaged for 5 h with a DIC filter (videos are provided as Supplementary Information). Still images from the videos are shown (second and fourth panels) together with the GFP expression (first panel) and merlin A-19 pAb staining (third panel). Arrows mark lamellipodia and arrowhead filopodia. Lamellipodia formation is impaired in S10A-expressing cells.
while S10D merlin stabilizes the filaments. Therefore, serine 10 is important for actin filament dynamics in vivo. We could not, however, detect any differences in the solubility, actin binding or actin depolymerization effect of S10 mutants compared to WT in vitro (data not shown). Thus, we hypothesize that the observed effect of merlin on actin cytoskeleton is indirect through merlin interaction partners regulating actin cytoskeleton.
Cell movement is induced by protrusion of a leading edge, movement of the cell body and finally by retraction of the cell. Nf2-deficient primary fibroblasts migrate faster than WT cells expressing merlin in wound-healing assays (Shaw et al., 2001 ), which we also observed in our studies with Nf2-deficient MEFs and Schwann cells. However, S10A merlin-expressing cells migrated even slower than the WT-infected cells. S10D cells migrated at a reduced rate between WT-and S10A-expressing cells (data not shown), indicating that regulation of the phosphorylation state of serine 10 is important for cell motility. S10A-transfected cells also displayed altered lamellipodia formation. The lamellipodium is critical for cell motility since it localizes protein complexes needed for actin polymerization (Small et al., 2002) . Thus, as proper formation of lamellipodia is impaired in S10A merlin-expressing cells, their ability to migrate may be altered.
It has been proposed that the very N-terminal sequence of merlin contains residues important for actin binding, and that this region may function as a common protein-binding motif (Brault et al., 2001; Golovnina et al., 2005) . Interestingly, Bai et al. (2007) recently showed that the first 50 amino acids of merlin contain regulatory residues that affect the interplay between merlin, ezrin, actin and CD44. Phosphorylation of serine 10 could be involved in regulating the formation of these complexes.
The results described in this study indicate that phosphorylation of serine 10 is an important factor in the functional regulation of merlin and that PKAdependent phosphorylation of serine 10 participates in cytoskeletal organization.
Materials and methods

Plasmids and antibodies
Human merlin isoform I (WT, amino acids 1-595) and isoform II (amino acids 1-590) in pcDNA3 vector (Invitrogen, Carlsbad, CA, USA) were used for transfection experiments. For expression of recombinant GST fusion proteins, the following constructs were used: merlin 1-100, merlin N terminus (amino acids 1-314), merlin 1-547, merlin C terminus (amino acids 492-595) and full-length ezrin, all in pGEX4T1 vector (Amersham Biosciences, Buckinghamshire, UK). Point mutations of merlin in all vectors were made by site-directed mutagenesis using the QuikChange Kit (Stratagene, La Jolla, CA, USA). WT or S518A merlin in pDEST27 vector (Invitrogen) containing an N-terminal GST tag was used for metabolic labeling. Merlin retro-and adenovirus constructs have been described previously (Schulze et al., 2002; Muranen et al., 2007) . GFP-a-actinin used in live cell imaging has also been described before (Hotulainen and Lappalainen, 2006 ). Anti-merlin pAb A-19 sc-331 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and mAb KF10 (den Bakker et al., 1995) were used to detect merlin. S518 phosphorylated merlin was detected with pS518 pAb (Biodesign, Saco, ME, USA). 3C12 mAb (Bo¨hling et al., 1996) was used for ezrin detection, Alexa-568-conjugated phalloidin (Invitrogen-Molecular Probes, Carlsbad, CA, USA) to detect F-actin and anti-GST polyclonal goat antibody (GE Healthcare, Budapest, Hungary) to detect GST proteins. Alexa-488-, Alexa-568-and Alexa-594-conjugated goat anti-mouse and goat anti-rabbit antibodies (Invitrogen-Molecular Probes) were used as secondary antibodies in immunofluorescence and HRPconjugated rabbit anti-mouse and swine anti-rabbit (both from DAKO A/S, Glostrup, Denmark) and swine anti-goat (Santa Cruz Biotechnology) secondary antibodies in western blot analysis.
Cell culture, transfections and immunoblotting 293 human embryonic kidney (HEK) cells were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) (PromoCell, Heidelberg, Germany). COS-7 cells, merlinÀ/À mouse embryonic fibroblasts (Nf2À/À MEFs) and 293A HEK cells were all grown in Dulbecco's minimum essential medium (DMEM, Gibco-Invitrogen, Carlsbad, CA, USA) with 10% FCS. Primary Nf2 knockout Schwann cells (Giovannini et al., 2000) were isolated and cultured as previously described (Manent et al., 2003) . The cells were immortalized and used before passage 20.
Cells were transfected using Fu-GENE6 reagent (Roche, Basel, Switzerland) and incubated for 48 h before analysis. Cells grown on glass coverslips were fixed in 3.5% paraformaldehyde (pH 7.5) for immunofluorescence. For western blotting, cells were rinsed with phosphate-buffered saline and lysed in ELB buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM EDTA) containing 0.5% Nonidet P-40 (NP-40), 1.5 mM okadaic acid (Calbiochem, San Diego, CA, USA), HALT phosphatase inhibitors (Pierce, Rockford, IL, USA) and Complete protease inhibitors (Roche). Lysed cells were centrifuged at 20 000 g for 30 min at þ 4 1C. Protein concentrations were determined by Bio-Rad Protein Assay (Bio-Rad, Hercules, CA, USA). Equal amounts of proteins were analysed by SDS-PAGE and immunoblotting.
Metabolic labeling
Forty-eight hours after merlin transfection, 293A HEK cells were changed into serum-and phosphate-free DMEM, and 1 mCi ml À1 of 32 P-labeled orthophosphate (Amersham Biosciences) was added for 2 h. Cells were treated with 50 mM IBMX and 25 mM forskolin or 40 mM H89 (all from SigmaAldrich, St Louis, MO, USA) for 30 min or 2 h respectively. Cells were lysed in ELB buffer with 1% NP-40, phosphatase inhibitors (HALT, 1.5 mM Calyculin A (Calbiochem), Cocktail Set IV (Calbiochem), 1.5 mM okadaic acid) and protease inhibitors, and centrifuged at 14 000 g for 30 min at þ 4 1C. Samples were diluted to a final concentration of 0.5% NP-40, glutathione Sepharose (Amersham Biosciences) was added to the lysates to pull down merlin and the samples were incubated overnight at þ 4 1C. Beads were washed with ELB buffer containing inhibitors, reducing Laemmli buffer was added and samples were run in 8% SDS-PAGE. Gels were silver stained following standard protocol, dried and exposed on a PhosphoImager plate, read by TyphoonImager 9400 and analysed by ImageQuant TL2003 software (all by GE Healthcare). The amount of bound orthophosphate was normalized to the merlin amount, and the background radioactivity (empty GST plasmid) was subtracted.
In vitro phosphorylation Glutathione S-transferase fusion proteins were expressed in Escherichia coli DH5a and purified. Glutathione-Sepharose beads to which 5 mg of fusion protein was conjugated were washed in PKA buffer (20 mM Tris-HCl, 10 mM MgCl 2 , pH 7.4). The phosphorylation reaction was carried out in a 30 ml buffer volume, including 10 mCi of [g-33 P]ATP (PerkinElmer, Waltham, MA, USA) and 2 ng of purified human recombinant PKA (Sigma-Aldrich) for 30 min at þ 30 1C. The reaction was stopped by washing the beads in PKA buffer and adding reducing Laemmli buffer. Samples were resolved by 12% SDS-PAGE. The gel was fixed and stained with Coomassie blue followed by exposure to a PhosphoImager plate and detection with Typhoon as previously described.
Merlin-Ezrin pull-down
Bacterially expressed full-length ezrin was cleaved from GST by thrombin (Sigma-Aldrich). Glutathione-Sepharose beads carrying 5 mg of merlin fusion proteins were washed in PKA buffer and phosphorylated by human recombinant PKA as described above except that 200 mM of cold ATP (SigmaAldrich) was used. After phosphorylation, beads were washed in binding buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, protease inhibitors). Four micrograms of thrombin-cleaved ezrin was incubated with phosphorylated or unphosphorylated merlin constructs under rotation for 2 h at þ 4 1C. Beads were washed with binding buffer, reducing Laemmli buffer was added and bound proteins were resolved in SDS-PAGE. Proteins were detected with ezrin and GST antibodies.
Actin stainings and quantification
Nf2À/À MEFs, transfected with WT, S10A, S10D or S518A, were stained with merlin pAb A-19 and phalloidin. Images were taken with Leica SP2 confocal microscope, equipped with Ar and Kr lasers (Leica Microsystems, Heerbrugg, Switzerland). For quantification of actin, cells were imaged with immunofluorescence microscopy (Zeiss Axiophot equipped with AxioCam cooled CCD camera, Carl Zeiss, Esslingen, Germany) using a fixed exposure of 900 ms for phalloidin. The intensity of the actin staining was measured from whole cells by Image J (v10.2) software. Total fluorescence from 20 merlin-transfected cells and untransfected cells from the same slides was analysed separately, and the staining intensities were normalized to the untransfected cells. The experiment was repeated three times with similar results.
Latrunculin B assay
Forty-eight hours after transfection, Nf2À/À MEFs were fixed (zero time point) or treated with 2.5 mM Latrunculin B (SigmaAldrich) for 8 min. Cells were stained for merlin and phalloidin and analysed with a fluorescence microscope.
Wound-healing assay and quantification For wound-healing assays, Nf2À/À MEFs and Nf2À/À Schwann cells (P18) were infected with retro-and adenovirus constructs, respectively, containing merlin WT, S10A or empty virus as previously described (Schulze et al., 2002; Muranen et al., 2007) . Plates were wounded 24-48 h after infection, and the wound healing was monitored. After 72 h, cells were fixed and stained with merlin A-19 pAb to control infection efficiency. Quantification of wound width was carried out by ImageJ software, and mean values and standard deviations were calculated. The experiment was repeated four times with similar results.
Live cell imaging
Nf2À/À MEFs were co-transfected with GFP-a-actinin and merlin 24-48 h before imaging. Cells were imaged with an inverted Olympus IX81 microscope and CellR program at þ 37 1C, 5% CO 2 . Images were taken every 30 s for 5 h. GFP expression images were taken before and after the experiment, and the cells were stained for merlin to verify expression. Imaging was done from seven cells of both constructs with similar results.
